Home › The Emperor Is 25% To 65% Naked: Valeant, Salix, And Cash EPS
 

Keywords :   


The Emperor Is 25% To 65% Naked: Valeant, Salix, And Cash EPS

2015-12-14 19:08:13| Biotech - Topix.net

Valeant's use of Cash EPS for depreciating durable assets seems inappropriate when applied to a finite portfolio of patent products like Salix. Using various depreciation schedules for the debt cost of acquiring Salix lowers VRX's cash EPS from 25% to 65%.

Tags: cash naked eps emperor

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
09.05Maryland Adopts PaintCare Program
09.05Society of Cosmetic Chemists Intermountain West to Host Healthy Bite Oral Care Symposium
09.05A.Celli and Akinal Tekstil Collaborate on Line Installation
09.05Record levels of shoplifting show signs of falling
09.05National Advertising Division Recommends Amyris Clean Beauty Modify Claim
09.05RTL Luxembourg deploys Verimatrix to protect auto racing from piracy
09.05Bank of England boss weighs in on UK economy row
09.05Roku and The Trade Desk announce data-driven streaming partnership
More »